Stimulated neuronal expression of brain-derived neurotrophic factor by Neurotropin

Molecular and Cellular Neuroscience

Volumn 45, Issue 3, 2010, Pages 226-233

  Fukuda, Yu ^a,b,e   Berry, Thomas L ^b   Nelson, Matthew ^c   Hunter, Christopher L ^c   Fukuhara, Koki ^b,d,e   Imai, Hideki ^e   Ito, Shinji ^a   Granholm Bentley, Ann Charlotte ^c   Kaplan, Allen P ^b   Mutoh, Tatsuro ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d NATIONAL INSTITUTE OF NURSING RESEARCH   (United States)

^e Nippon Zoki Pharmaceutical Co   (Japan)

Author keywords

Brain derived neurotrophic factor; CREB pathway; Down's syndrome; Neurotropin; Radial arm maze; TrkB; Ts65Dn mice

Indexed keywords

ANALGESIC AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; NEUROTROPIN; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LINE; CHRONIC PAIN; COGNITION; CONTROLLED STUDY; DEGENERATIVE DISEASE; HIPPOCAMPUS; HUMAN; HUMAN CELL; MOUSE; NERVE DEGENERATION; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DOWN SYNDROME; HIPPOCAMPUS; HUMANS; MALE; MEMORY; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NEUROBLASTOMA; NEURONS; POLYSACCHARIDES; RABBITS; RECEPTOR, TRKB; TUMOR CELLS, CULTURED;

MUS; ORYCTOLAGUS CUNICULUS; VACCINIA VIRUS;

EID: 77956616429     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2010.06.013     Document Type: Article

References (59)

1. Angelucci F., Mathé A.A., Aloe L. Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia. Prog. Brain Res. 2004, 146:151-165.
2. Balkowiec A., Katz D.M. Activity-dependent release of endogenous brain-derived neurotrophic factor from primary sensory neurons detected by ELISA in situ. J. Neurosci. 2000, 20:7417-7423.
3. Bimonte H.A., Nelson M.E., Granholm A.C. Age-related deficits as working memory load increases: relationships with growth factors. Neurobiol. Aging 2003, 24:37-48.
4. Bimonte-Nelson H.A., Hunter C.L., Nelson M.E., Granholm A.C. Frontal cortex BDNF levels correlate with working memory in an animal model of Down syndrome. Behav. Brain Res. 2003, 139:47-57.
5. Chen M.J., Nguyen T.V., Pike C.J., Russo-Neustadt A.A. Norepinephrine induces BDNF and activates the PI-3K and MAPK cascades in embryonic hippocampal neurons. Cell. Signal. 2007, 19:114-128.
6. Davis A.M., Wright E.M. Neurotrophin autocrine loops. Curr. Biol. 1995, 5:723-726.
7. Davisson M.T., Schmidt C., Akeson E.C. Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome. Prog. Clin. Biol. Res. 1990, 360:263-280.
8. de Reuck J., Decco D., Vanderdonckt P., Dallenga A., Ceusters W., Kalala J.P., De Meulemeester K., Abdullah J., Santens P., Huybrechts J., Spiers R., De Bleecker J., Tack I., Tack E., Vogels C., Boon P. A double-blind study of Neurotropin in patients with acute ischemic stroke. Acta Neurol. Scand. 1994, 89:329-335.
9. Ditlevsen D.K., Owczarek S., Berezin V., Bock E. Relative role of upstream regulators of Akt, ERK and CREB in NCAM- and FGF2-mediated signalling. Neurochem. Int. 2008, 53:137-147.
10. Duric V., McCarson K.E. Hippocampal neurokinin-1 receptor and brain-derived neurotrophic factor gene expression is decreased in rat models of pain and stress. Neuroscience 2005, 133:999-1006.
11. Duric V., McCarson K.E. Neurokinin-1 (NK-1) receptor and brain-derived neurotrophic factor (BDNF) gene expression is differentially modulated in the rat spinal dorsal horn and hippocampus during inflammatory pain. Mol. Pain 2007, 3:32-40.
12. Finkbeiner S., Tavazoie S.F., Maloratsky A., Jacobs K.M., Harris K.M., Greenberg M.E. CREB: a major mediator of neuronal neurotrophin responses. Neuron 1997, 19:1031-1047.
13. Fukumoto S., Mutoh T., Hasegawa T., Miyazaki H., Okada M., Goto G., Furukawa K., Urano T. GD3 synthase gene expression in PC12 cells results in the continuous activation of TrkA and Erk1/2 and enhanced proliferation. J. Biol. Chem. 2000, 275:5832-5838.
14. Gould E., McEwen B.S. Neuronal birth and death. Curr. Opin. Neurobiol. 1993, 3:676-682.
15. Granholm A.C., Sanders L., Seo H., Lin L., Ford K., Isacson O. Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndrome. Hippocampus 2003, 13:905-914.
16. Guo W., Robbins M.T., Wei F., Zou S., Dubner R., Ren K. Supraspinal brain-derived neurotrophic factor signaling: a novel mechanism for descending pain facilitation. J. Neurosci. 2006, 26:126-137.
17. Hamano T., Mutoh T., Tabira T., Araki W., Kuriyama M., Mihara T., Yano S., Yamamoto H. Abnormal intracellular trafficking of high affinity nerve growth factor receptor, Trk, in stable transfectants expressing presenilin 1 protein. Brain Res. Mol. Brain Res. 2005, 137:70-76.
18. Henkel A.W., Sperling W., Rotter A., Reulbach U., Reichardt C., Bonsch D., Maler J.M., Kornhuber J., Wiltfang J. Antidepressant drugs modulate growth factors in cultured cells. BMC Pharmacol. 2008, 8:6.
19. Hirota K., Matsui M., Murata M., Takashima Y., Cheng F.S., Itoh T., Fukuda K., Yodoi J. Nucleoredoxin, glutaredoxin, and thioredoxin differentially regulate NF-kappaB, AP-1, and CREB activation in HEK293 cells. Biochem. Biophys. Res. Commun. 2000, 274:177-182.
20. Hoshino Y., Nakamura T., Sato A., Mishima M., Yodoi J., Nakamura H. Neurotropin demonstrates cytoprotective effects in lung cells through the induction of thioredoxin-1. Am. J. Respir. Cell Mol. Biol. 2007, 37:438-446.
21. Hunter C.L., Isacson O., Nelson M., Bimonte-Nelson H., Seo H., Lin L., Ford K., Kindy M.S., Granholm A.C. Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down's syndrome. Neurosci. Res. 2003, 45:437-445.
22. Hunter C.L., Mimonte H.A., Granholm A.C. Behavioral comparison of 4 and 6month-old Ts65Dn mice: age-related impairments in working and reference memory. Behav. Brain Res. 2003, 138:121-131.
23. Hunter C.L., Bachman D., Granholm A.C. Minocycline prevents cholinergic loss in a mouse model of Down's syndrome. Ann. Neurol. 2004, 56:675-688.
24. Jessen U., Novitskaya V., Pedersen N., Serup P., Berezin V., Bock E. The transcription factors CREB and c-Fos play key roles in NCAM-mediated neuritogenesis in PC12-E2 cells. J. Neurochem. 2001, 79:1149-1160.
25. Kaplan D.R., Martin-Zanca D., Parada L.F. Tyrosine phosphorylation and tyrosine kinase activity of the trk-proto oncogene product induced by NGF. Nature 1991, 350:158-160.
26. Kaplan D.R., Matsumoto K., Lucarelli E., Thiele C.J. Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Neuron 1993, 11:321-331.
27. Kawamura M., Ohara H., Go K., Koga Y., Ienaga K. Neurotropin induces antinociceptive effect by enhancing descending pain inhibitory systems involving 5-HT3 and noradrenergic alpha2 receptors in spinal dorsal horn. Life Sci. 1998, 62:2181-2190.
28. Kawashiri T., Egashira N., Itoh Y., Shimazoe T., Ikegami Y., Yano T., Yoshimura M., Oishi R. Neurotropin reverses paclitaxel-induced neuropathy without affecting anti-tumour efficacy. Eur. J. Cancer 2009, 45:154-163.
29. Kimura H., Nakamura S., Okamoto K., Toyama I., Watanabe M., Ikeuchi K. A pilot study for clinical applications of Neurotropin to senile patients with dementia. Jpn Pharmacol. Ther. 1987, 15:407-423.
30. Kita T., Hata T., Iida J., Yoneda R., Isida S. Decrease in pain threshold in SART stressed mice. Jpn J. Pharmacol. 1979, 29:479-482.
31. Kozisek M.E., Middlemas D., Bylund D.B. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies. Pharmacol. Ther. 2008, 117:30-51.
32. Lee E., Son H. Adult hippocampal neurogenesis and related neurotrophic factors. BMB Rep. 2009, 42:239-244.
33. Malcangio M., Lessmann V. A common thread for pain and memory synapses? Brain-derived neurotrophic factor and TrkB receptors. Trends Pharmacol. Sci. 2003, 24:116-121.
34. Masutani H., Bai J., Kim Y.C., Yodoi J. Thioredoxin as a neurotrophic cofactor and an important regulator of neuroprotection. Mol. Neurobiol. 2004, 29:229-242.
35. Miura T., Okazaki R., Yoshida H., Namba H., Okai H., Kawamura M. Mechanism of analgesic action of Neurotropin on chronic pain in adjuvant-arthritic rat: roles of descending noradrenergic and serotonergic systems. J. Pharmacol. Sci. 2005, 97:429-436.
36. Morita S., Takeoka Y., Imai H., Yamamoto H., Suehiro S., Ueda S., Katoh S. Differential action of nerve growth factor, cyclic AMP and Neurotropin on PC12h cells. Cell Struc. Funct. 1988, 13:227-234.
37. Muneshige H., Toda K. Medication by Neurotropin for reflex sympathetic dystrophy (RSD). J. Musculoskeletal System 1996, 9:1199-1203. (in Japanese).
38. Mutoh T., Tokuda A., Miyadai T., Hamaguchi M., Fujiki N. Ganglioside GM1 binds to the Trk protein and regulates receptor function. Proc. Natl Acad. Sci. USA 1995, 92:5087-5091.
39. Nagaoka S., Nakamura M., Sekiguchi A. An open clinical trial of Neurotropin in patients with fibromyalgia. Rheumatology 2004, 32:104-108. (in Japanese).
40. Ohara H., Kawamura M., Namimatsu A., Miura T., Yoneda R., Hata T. Mechanism of hyperalgesia in SART stressed (repeated cold stress) mice: antinociceptive effect of Neurotropin. Jpn J. Pharmacol. 1991, 57:243-250.
41. Ono K., Inoue A., Hamada H., Ogawa N. Clinical evaluation of Neurotropin tablets (NT) on low back pain: a placebo-controlled double-blind study using Ibuprofen tablets (IT) as a basic treatment. Jpn Pharmacol. Ther. 1982, 10:5813-5832. (in Japanese).
42. Ono K., Ochi T., Yonenobu S., Ogawa N. Usefulness of Neurotropin tablets for low back pain and neck-shoulder-arm syndrome: a ketoprofen and placebo double blind controlled study. J. Clin. Report 1987, 21:837-873. (in Japanese).
43. Orimo H., Nakamura T., Ohsawa N., Kanazawa Y., Tojima T., Ohtake M., Santo H., Itagaki T., Suzuki T., Ito H., Aiso Y., Sawada T. Therapeutic effect of Neurotropin tablets on diabetic neuropathy. Prog. Med. 1989, 9:1153-1160.
44. Patapoutian A., Reichardt L.F. Trk receptors: mediators of neurotrophin action. Curr. Opin. Neurobiol. 2001, 11:272-280.
45. Pezet S., Malcangio M. Brain-derived neurotrophic factor as a drug target for CNS disorders. Expert Opin. Ther. Targets 2004, 8:391-399.
46. Pezet S., Malcangio M., McMahon S.B. BDNF: a neuromodulator in nociceptive pathways?. Brain Res. Brain Res. Rev. 2002, 40:240-249.
47. Saleh M.R., Muneshige H., Ikuta Y. Effects of Neurotropin on hyperalgesia and allodynia in mononeuropathic rats. Life Sci. 1998, 63:1931-1938.
48. Schmidt H.D., Duman R.S. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav. Pharmacol. 2007, 18:391-418.
49. Serres F., Carney S.L. Nicotine regulates SH-SY5Y neuroblastoma cell proliferation through the release of brain-derived neurotrophic factor. Brain Res. 2006, 1101:36-42.
50. Sobue I., Tashiro K., Hanakago R., Ando K., Yamada T., Iida M., Nishitani H., Saida K., Konishi T., Takayanagi T., Doi R., Ohmura I., Hirose N., Takase Y., Iwashita H., Koike F., Igata A., Tanabe H., Matsumoto A., Ogawa N., Hirai S. Clinical evaluation of neurotropin injections on dysesthesia of SMON (subacute myelo-optico-neuropathy) - a multi-institutional double-blind comparative study 1992, (in Japanese).
51. Soiampornkul R., Tong L., Thangnipon W., Balazs R., Cotman C.W. Interleukin-1Β interferes with signal transduction induced by neurotrophin-3 in cortical neurons. Brain Res. 2008, 1188:189-197.
52. Suzuki T., Li Y.H., Mashimo T. The antaiallodynic and antihyperalgesic effects of Neurotropin in mice with spinal nerve ligation. Anesth. Analg. 2005, 101:793-799.
53. Toda K., Muneshige H., Ikuta Y. Antinociceptive effects of Neurotropin in a rat model of painful peripheral mononeuropathy. Life Sci. 1998, 62:913-921.
54. Tsai S.J. Possible involvement of brain-derived neurotrophic factor in the antinociceptive effect of antidepressants in neuropathic pain. Med. Hypothesis 2005, 65:530-533.
55. Verdu B., Decosterd I., Buclin T., Stiefel F., Berney A. Antidepressants for the treatment of chronic pain. Drugs 2008, 68:2611-2632.
56. Yamamoto M., Sobue G., Yamamoto K., Terao S., Mitsuma T. Expression of mRNAs for neurotrophic factors (NGF, BDNF, NT-3, and GDNF) and their receptors (p75NGFR, TrkA, TrkB, and TrkC) in the adult human peripheral nervous system and nonneural tissues. Neurochem. Res. 1996, 21:929-938.
57. Yamamura H., Dan K., Wakasugi B., Hyodo M., Totoki T., Shigematsu A., Ebihara A. Effect of Neurotropin tablets on post-herpetic neuralgia: a multicenter double blind placebo controlled study. J. Clin. Exp. Med. 1988, 147:651-664. (in Japanese).
58. Yoneda R. SART-stress induced pathophysiological functions and effects of Neurotropin. Stress: Neuroendocrine and Molecular Approaches 1992, 767-789. Gordon and Breach Science, New York. R. Kvetnansly, R. McCarty, J. Axelrod (Eds.).
59. York R.D., Molliver D.C., Grewal S.S., Stenberg P.E., McCleskey E.W., Stork P.J. Role of phosphoinositide 3-kinase and endocytosis in nerve growth factor-induced extracellular signal-regulated kinase activation via Ras and Rap1. Mol. Cell. Biol. 2000, 20:8069-8083.